Paulic Meunerie faces EUR 0.46 million tax adjustment request tied to R&D credit review
Reuters2026/07/31 18:14- Paulic Meunerie flagged a tax audit challenge tied to its research tax credit in 1H 2026 accounts.
- Tax authorities issued a proposed adjustment of about EUR 0.46 million.
- The company expects to book a provision in its 2026 interim financial statements.
- No immediate cash impact was indicated while discussions with the tax administration continue under appeal procedures.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Spot bitcoin ETFs pull in $987 million last week as institutional demand recovers
Silver Price Forecast: XAG/USD dips below $66.00 and hints at a bearish “H&S”
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well
Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.
Crypto prices
More
